ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag policy innovation cloning evolution

2018 Top 10 Innovations
The Scientist | Dec 1, 2018 | 10+ min read
Biology happens on many levels, from ecosystems to electron transport chains. These tools may help spur discoveries at all of life's scales.
bacteria inside a biofilm
How Bacterial Communities Divvy up Duties
Holly Barker, PhD | Jun 1, 2023 | 10+ min read
Biofilms are home to millions of microbes, but disrupting their interactions could produce more effective antibiotics.
Genome Investigator Craig Venter Reflects On Turbulent Past And Future Ambitions
Karen Young Kreeger | Jul 23, 1995 | 8 min read
And Future Ambitions Editor's Note: For the past four years, former National Institutes of Health researcher J. Craig Venter has been a major figure in the turbulent debates and scientific discoveries surrounding the study of genes and genomes. Events heated up in 1991, when NIH attempted to patent gene fragments, which were isolated using Venter's expressed sequence tag (EST)/complementary DNA (cDNA) approach for discovering human genes (M.A. Adams et al., Science, 252:1651-6, 1991). NIH's mo
Combinatorial Libraries: Life's Tinker Toys
Gail Dutton | May 18, 2003 | 9 min read
Courtesy of UC Davis Medical Center  COMBI-KING: Kit Lam brings his expertise in combinatorial chemistry, an innovative technique for creating millions of new chemical compounds in just days, to the UC Davis Cancer Center. It's the new mix and match. In the computer industry, programmers refer to modularity--the ability to shuffle different sections of computer code to create new software. In the life sciences, the modules are peptides or molecular fragments that can be combined to yield
Scientific Enterprise At Critical Juncture, Say Panelists, Researchers
Steven Benowitz | Oct 13, 1996 | 10+ min read
MISCONDUCT POLICY: University of Illinois' C.K. Gunsalus cites problems of oversight in academia. Is science in crisis? Scientists, historians, administrators, and others have debated this issue over the last few decades. The controversial topic was the impetus for a September 19 conference at George Washington University (GWU). Panelists at the day-long symposium, titled "Science in Crisis at the Millennium," think something has gone awry. Keith Yamamoto, University of California, San Franc
The Biggest Stories in Bioscience 2005
Ishani Ganguli | Dec 4, 2005 | 8 min read
Life scientists have been challenged more than ever this year not just to critically analyze data, but to better interpret those data for an increasingly critical public.
Automated Colony Pickers Evolve
Helen Dell(hdell@the-scientist.com) | Jul 3, 2005 | 6 min read
Everyone knows that the first genome sequencing projects took years of work and represent the combined product of tens of thousands of individual fragments.
Promises, Promises
Stuart Blackman | Nov 1, 2009 | 10+ min read
.table { background: #95332E; color: #ffffff; font-family: "Trebuchet MS", Arial, Helvetica, sans-serif; text-align: center; padding: 8px 0; }.prediction_table { background: #95332E; color: #ffffff; font-size: 11px; font-family: "Trebuchet MS", Arial, Helvetica, sans-serif; }.prediction_table td, .prediction_table th { padding: 5px; border-bottom: 2px solid #ffffff; }.short { padding: 0 25px; }.sidebar { border-left:10px solid #95332E; background
The Future of Public Engagement
Matthew C. Nisbet & Dietram A. Scheufele | Oct 1, 2007 | 10 min read
The Future of Public Engagement The facts never speak for themselves, which is why scientists need to "frame" their messages to the public. By Matthew C. Nisbet & Dietram A. Scheufele Related Articles 1 Page is just one of several leaders who have called attention to the urgent need for new directions in science communication. Yet unfortunately, still missing from much of the general discussion is a systematic understanding of how the public uses the media to form
Insider-Trading Case Poses Concerns For Researchers
Thomas Durso | Jun 8, 1997 | 8 min read
EVOLVING PARADIGM: Allison Rosenberg of the Government-University-Industry Roundtable feels the insider-trading case reflects changes in drug research funding. The United States Securities and Exchange Commission (SEC) has sent waves of concern through the scientific community by bringing what it calls its first insider-trading case against drug researchers. It is illegal to trade stocks while in possession of information not available to the general public or to inform other traders of such i

Run a Search

ADVERTISEMENT